Antilymphocyte Serum: all 156 studies that test it
Page 2 of 2. Open to participants first (16), then studies with results posted, then the rest; newest registration first within each.
- Different Doses of Anti-thymocyte Globin to Treat Child Severe Aplastic AnemiaStatus unknownNCT01997372Phase 4
- Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood TransplantationStatus unknownNCT01983761Phase 1/2
- ATG in Haploidentical HSCT for Acute Graft-versus-host Disease ProphylaxisCompletedNCT01883180Phase 4
- Anti-thymocyte Globulins for Graft-versus-host Disease ProphylaxisCompletedNCT01856803Phase 4
- Haploidentical Stem Cell Transplantation for Children With Acquired Severe Aplastic AnemiaStatus unknownNCT01759732Phase 2
- Dose Escalation Trial of WT1-specific Donor-derived T Cells Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed/Refractory Multiple MyelomaCompletedNCT01758328Phase 1
- Allogeneic Hematopoietic Stem Cell Transplantation Using a Non-myeloablative Preparative Regimen of Total Lymphoid Irradiation and Anti-thymocyte Globulin for Older Patients With Relapsed Lymphoid MalignanciesCompletedNCT01566656Phase 2
- Allogeneic Stem Cell Transplantation in Children and Adolescents With Acute Lymphoblastic LeukaemiaStatus unknownNCT01423747Phase 3
- ALL-SCT BFM International- HSCT in Children and Adolescents With ALLStatus unknownNCT01423500Phase 3
- Allogenic Haematopoietic Cell Transplantation for Patients With Refractory "Triple Negative" Breast CancerTerminatedNCT01375023Phase 2
- Thymoglobulin Induction in Kidney Transplant RecipientsStatus unknownNCT01239563Phase 3
- Fludarabine Phosphate, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Peripheral Blood Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Myeloid MalignanciesCompletedNCT01056614Phase 2
- Donor Stem Cell Transplant or Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia in RemissionCompletedNCT01020734Phase 2
- Allogeneic Stem Cell Transplantation Followed By Targeted Immune Therapy In Average Risk LeukemiaCompletedNCT01020539Phase 1
- Risk-Adapted Allogeneic Stem Cell Transplantation For Mixed Donor Chimerism In Patients With Non-Malignant DiseasesCompletedNCT01019876Phase 2/3
- Safety and Efficacy of ProHema Modulated Umbilical Cord Blood Units in Subjects With Hematologic Malignancies.CompletedNCT00890500Phase 1
- Tandem Stem Cell Transplantation for Non-Hodgkin's LymphomaActive, not recruitingNCT00882895Phase 2
- Combined Bone Marrow Transplantation (BMT) and Renal Transplant for Multiple Myeloma (MM) With End Stage Renal Disease (ESRD)CompletedNCT00854139Phase 1
- Autologous Stem Cell Transplant for Neurologic Autoimmune DiseasesActive, not recruitingNCT00716066Phase 2
- Thymoglobulin: Presence and Affect in the Central Lymphatic CompartmentCompletedNCT00714480Not applicable
- Role of Intraoperative Thymoglobulin in Decreasing Ischemia-Reperfusion Injury in Pediatric Heart Transplant RecipientsWithdrawnNCT00709293Not applicable
- Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell TransplantCompletedNCT00697684Phase 1
- Benefit of Immunoprophylaxis on Fibrosis to Reduce Viral Load After Liver TransplantationCompletedNCT00538265Phase 4
- Antithymocyte Globulin and Cyclosporine in Treating Low Risk Patients With Myelodysplastic SyndromeCompletedNCT00488436Phase 4
- B-Lymphocyte Immunotherapy in Islet TransplantationTerminatedNCT00468442Phase 2
- Efficacy of Islet After Kidney TransplantationCompletedNCT00468117Phase 3
- Effects of Antithymocyte Globulin in Adults With Myelodysplastic SyndromeStatus unknownNCT00466843Phase 2
- Strategies to Improve Islet SurvivalCompletedNCT00464555Phase 2
- Islet Transplantation in Type 1 DiabetesCompletedNCT00434811Phase 3
- Antithymocyte Globulin in Treating Patients Undergoing Stem Cell Transplant for Multiple MyelomaCompletedNCT00378768Phase 2
- Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell TransplantCompletedNCT00376480Phase 1
- Antithymocyte Globulin and Sirolimus in Treating Patients With Relapsed Multiple MyelomaCompletedNCT00317798Phase 1
- Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic CancerCompletedNCT00304018Phase 1
- Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic CancerCompletedNCT00301951Phase 1
- Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic CancerCompletedNCT00296023Not applicable
- Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency DiseaseCompletedNCT00295971Phase 1
- Anti-Thymocyte Globulin, Cyclosporine, and RAD in Islet TransplantationCompletedNCT00286624Phase 1/2
- IMM 0212: Busulfan With Fludarabine and Antithymocyte Globulin as Preparative Therapy for Hematopoietic Stem Cell Transplant for the Treatment of Severe Congenital T-Cell ImmunodeficiencyCompletedNCT00228852Phase 1/2
- To Determine the Role of Adding Campath-1H or ATG Given In-vivo in Addition to Fludarabine and Low Dose Busulfex on Outcome in Patients Treated With Reduced Intensity ConditioningWithdrawnNCT00226512Phase 3
- Anti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic SyndromesCompletedNCT00217386Phase 2
- Early Allogeneic Blood Stem Cell Transplantation in High-risk Acute Myeloid Leukemia (AML)CompletedNCT00188136Phase 2
- Stem Cell Transplantation With Identical Donors for Patients With Sickle Cell DiseaseCompletedNCT00186810Phase 2
- Improving Immunosuppressive Treatment for Patients With Severe Aplastic AnemiaCompletedNCT00061360Phase 2
- Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic AnemiaCompletedNCT00054236Phase 1
- Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic CancerCompletedNCT00053196Phase 2
- Antithymocyte Globulin Compared With Supportive Care in Treating Patients With Myelodysplastic SyndromeCompletedNCT00017550Phase 2
- Phase II Pilot Study of Cyclophosphamide and Rabbit Anti-Thymocyte Globulin as Salvage Therapy in Patients With Diffuse Systemic SclerosisCompletedNCT00016458Phase 2
- S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic SyndromeCompletedNCT00016419Phase 2
- Phase I Pilot Study of Total-Body Irradiation, Anti-Thymocyte Globulin and Cyclophosphamide Followed By Syngeneic or Autologous Peripheral Blood Stem Cell Transplantation in Patients With Multiple SclerosisCompletedNCT00014755Phase 1
- Antithymocyte Globulin and Cyclosporine in Treating Patients With Myelodysplastic SyndromeCompletedNCT00004208Phase 3
- Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerCompletedNCT00004145Phase 2
- T-cell Depleted Bone Marrow and G-CSF Stimulated Peripheral Stem Cell Transplantation From Related Donors in Treating Patients With Leukemia, Lymphoblastic Lymphoma, Myelodysplastic Syndrome, or Aplastic AnemiaCompletedNCT00002718Phase 2
- Combination Therapy of Severe Aplastic AnemiaCompletedNCT00001964Phase 2
- A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic SyndromeCompletedNCT00001839Phase 2
- Medical Treatment for Diamond Blackfan AnemiaCompletedNCT00001749Phase 2
- Comparing Therapies for the Treatment of Severe Aplastic AnemiaCompletedNCT00001626Phase 2